Stockholm, August 17, 2023 - Intervacc AB (publ) announces that it has been awarded an “industrial research” grant from Vinnova as part of a project with Testa Center, Uppsala, Sweden, to optimise the manufacturing ... Read more
Stockholm, July 11, 2023 - Intervacc AB (publ) announces the initiation of a project with Testa Center, Uppsala, to optimise the development of manufacturing processes for a prototype vaccine in pigs.
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH ... Read more
Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Wednesday 7 June 2023, at which the following resolutions were made.
Adoption of the income statement ... Read more
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH ... Read more